Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.4%

58 terminated/withdrawn out of 510 trials

Success Rate

81.9%

-4.6% vs industry average

Late-Stage Pipeline

13%

68 trials in Phase 3/4

Results Transparency

41%

107 of 263 completed trials have results

Key Signals

75 recruiting107 with results40 terminated18 withdrawn

Enrollment Performance

Analytics

N/A
202(51.0%)
Phase 2
64(16.2%)
Phase 1
51(12.9%)
Phase 4
40(10.1%)
Phase 3
28(7.1%)
Early Phase 1
11(2.8%)
396Total
N/A(202)
Phase 2(64)
Phase 1(51)
Phase 4(40)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (510)

Showing 20 of 510 trials
NCT05487846Not ApplicableRecruiting

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

Role: lead

NCT06414590Phase 2Recruiting

Neoadjuvant Tebentafusp for Uveal Melanoma

Role: lead

NCT07436364Early Phase 1Recruiting

Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Role: lead

NCT07526480Not ApplicableNot Yet Recruiting

Improving Dementia Care in Primary Practice

Role: lead

NCT07246057Not ApplicableRecruiting

Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships

Role: collaborator

NCT02872831Not ApplicableWithdrawn

Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle

Role: lead

NCT04721886Early Phase 1Completed

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

Role: lead

NCT07501650Phase 1Recruiting

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Role: lead

NCT03773575Not ApplicableCompleted

Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputation Wound Complications

Role: lead

NCT06089954Not ApplicableEnrolling By Invitation

Penn Medicine Biobank Return of Results Program

Role: collaborator

NCT05929664Phase 2Recruiting

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Role: lead

NCT07221786Not ApplicableRecruiting

Preoperative Opioid Tapering Before Spine Surgery

Role: lead

NCT07462403Not ApplicableActive Not Recruiting

A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa

Role: lead

NCT07478016Recruiting

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

Role: lead

NCT07387354Phase 1Not Yet Recruiting

Pacritinib With Aza for Upfront Myelodysplastic Syndrome

Role: lead

NCT04788277Recruiting

Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)

Role: lead

NCT06260891Phase 2Recruiting

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

Role: collaborator

NCT06530693Not ApplicableRecruiting

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

Role: collaborator

NCT05627232Phase 1Recruiting

Tazemetostat and Palbociclib With CPX-351for R/R AML

Role: lead

NCT07218588Not ApplicableRecruiting

Sanctuary Farm Prescription in Adolescents

Role: collaborator